BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Prognosis
2768 results:

  • 1. Metastatic Merkel Cell Carcinoma After Simultaneous Pancreas-kidney Transplantation: Fatal Outcomes.
    Burke O; Labib A; Burke G; Beer J; Nichols A
    J Drugs Dermatol; 2024 May; 23(5):376-379. PubMed ID: 38709686
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
    Pan W; Liu X; Liu S
    Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Heterotopic bone formation in a case of clear cell renal cell carcinoma: A case report.
    Bavikar R; Patel P; Verma A; Ingale Y; Randive R
    J Cancer Res Ther; 2024 Jan; 20(1):482-484. PubMed ID: 38554371
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
    Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
    Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.
    Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J
    Cancer Med; 2024 Apr; 13(7):e7113. PubMed ID: 38545824
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
    Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
    Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
    Gong X; Gong Y; Wu G; Ke H
    Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
    Dai L; Pan D; Jin J; Lv W
    Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
    Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
    Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
    Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
    Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Correlation of 1p/16q loss of heterozygosity and 1p gain with clinicopathological characteristics and prognosis in Wilms tumor].
    Jia C; Yao XF; Zhang M; Guan XX; Wang JW; Song HC; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):257-263. PubMed ID: 38433053
    [No Abstract]    [Full Text] [Related]  

  • 16. Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics.
    Zhong Z; Hou J; Yao Z; Dong L; Liu F; Yue J; Wu T; Zheng J; Ouyang G; Yang C; Song J
    Nat Commun; 2024 Mar; 15(1):1929. PubMed ID: 38431724
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Natural history of bone-only metastasis in renal cell carcinoma.
    Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
    Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of a nomogram for predicting the impact of tumor size on cancer-specific survival of locally advanced renal cell carcinoma: a SEER-based study.
    Bai J; Lu Q; Wen Y; Shangguan T; Ye Y; Lin J; Liu R; Cai W; Chen J
    Aging (Albany NY); 2024 Feb; 16(4):3823-3836. PubMed ID: 38376430
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
    Wu XW; Zhou PP; Dong Q
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
    Yang W; Liu Z; Liu T
    Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 139.